These studies describe the activities of a novel S1P1 agonist (AKP-11) that produces milder and reversible lymphopenia as compared to FTY720 producing a greater loss of S1P1 and thus prolonged lymphopenia. The gene discussed is S1PR1; the disease is lymphopenia.